New Risk • May 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: HK$74.0m (US$9.45m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Annuncio • Apr 30
China Energy Storage Technology Development Limited, Annual General Meeting, Jun 12, 2026 China Energy Storage Technology Development Limited, Annual General Meeting, Jun 12, 2026, at 10:00 China Standard Time. Location: units 5906-5912, 59th floor, the center, 99 queens road central, Hong Kong Reported Earnings • Apr 02
Full year 2025 earnings released: HK$0.20 loss per share (vs HK$0.039 profit in FY 2024) Full year 2025 results: HK$0.20 loss per share (down from HK$0.039 profit in FY 2024). Revenue: HK$359.7m (down 25% from FY 2024). Net loss: HK$44.4m (down HK$52.6m from profit in FY 2024). Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings. Annuncio • Mar 31
Fame Castle Enterprises Limited proposed to acquire remaining 76.37% stake in China Energy Storage Technology Development Limited (SEHK:1143) for HKD 77.1 million. Fame Castle Enterprises Limited proposed to acquire remaining 76.37% stake in China Energy Storage Technology Development Limited (SEHK:1143) for HKD 77.1 million on March 30, 2026. There are 224,289,185 Shares in issue, and there are 171,289,185 Scheme Shares (representing approximately 76.37% of the issued share capital of the Company) in issue; and (ii) 15,550,182 outstanding Share Options. Mr. Lin has made an irrevocable and unconditional undertaking to the Company and the Offeror that he will not exercise the 1,725,291 outstanding Share Options held by him at any time prior to the expiry of one month after the Effective Date and will not accept the Option Proposal in respect thereof.
The expected completion of the transaction is September 30, 2026.
Lego Corporate Finance Limited acted as financial advisor for Fame Castle Enterprises Limited. Board Change • Mar 31
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non-Executive Director Xiulin Zhang was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Annuncio • Mar 13
China Energy Storage Technology Development Limited to Report Fiscal Year 2025 Results on Mar 31, 2026 China Energy Storage Technology Development Limited announced that they will report fiscal year 2025 results on Mar 31, 2026 Reported Earnings • Oct 05
First half 2025 earnings released: HK$0.073 loss per share (vs HK$0.02 loss in 1H 2024) First half 2025 results: HK$0.073 loss per share (further deteriorated from HK$0.02 loss in 1H 2024). Revenue: HK$188.2m (down 29% from 1H 2024). Net loss: HK$16.3m (loss widened 316% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 31
First half 2025 earnings released: HK$0.073 loss per share (vs HK$0.02 loss in 1H 2024) First half 2025 results: HK$0.073 loss per share (further deteriorated from HK$0.02 loss in 1H 2024). Revenue: HK$188.2m (down 29% from 1H 2024). Net loss: HK$16.3m (loss widened 316% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Annuncio • Aug 20
China Energy Storage Technology Development Limited has withdrawn its Follow-on Equity Offering in the amount of HKD 14.80248 million. China Energy Storage Technology Development Limited has withdrawn its Follow-on Equity Offering in the amount of HKD 14.80248 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 44,856,000
Price\Range: HKD 0.33
Transaction Features: Subsequent Direct Listing Annuncio • Aug 15
China Energy Storage Technology Development Limited to Report First Half, 2025 Results on Aug 29, 2025 China Energy Storage Technology Development Limited announced that they will report first half, 2025 results on Aug 29, 2025 New Risk • Jul 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (32% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (HK$90.8m market cap, or US$11.6m). Annuncio • Jun 24
China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 14.80248 million. China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 14.80248 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 44,856,000
Price\Range: HKD 0.33
Transaction Features: Subsequent Direct Listing Annuncio • Jun 21
China Energy Storage Technology Development Limited has withdrawn its Follow-on Equity Offering in the amount of HKD 94.201458 million. China Energy Storage Technology Development Limited has withdrawn its Follow-on Equity Offering in the amount of HKD 94.201458 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 448,578,370
Price\Range: HKD 0.21
Discount Per Security: HKD 0.00315
Transaction Features: Rights Offering New Risk • May 08
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 32% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (32% accrual ratio). Market cap is less than US$10m (HK$65.0m market cap, or US$8.37m). Annuncio • Apr 30
China Energy Storage Technology Development Limited, Annual General Meeting, Jun 20, 2025 China Energy Storage Technology Development Limited, Annual General Meeting, Jun 20, 2025, at 10:00 China Standard Time. Location: units 5906-5912, 59th floor, the center, 99 queens road central, Hong Kong Reported Earnings • Apr 02
Full year 2024 earnings released: EPS: HK$0.039 (vs HK$0.031 in FY 2023) Full year 2024 results: EPS: HK$0.039 (up from HK$0.031 in FY 2023). Revenue: HK$479.3m (down 4.5% from FY 2023). Net income: HK$8.17m (up 55% from FY 2023). Profit margin: 1.7% (up from 1.0% in FY 2023). Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings. Annuncio • Mar 14
China Energy Storage Technology Development Limited to Report Fiscal Year 2024 Results on Mar 28, 2025 China Energy Storage Technology Development Limited announced that they will report fiscal year 2024 results on Mar 28, 2025 Annuncio • Dec 14
China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 94.201458 million. China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 94.201458 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 448,578,370
Price\Range: HKD 0.21
Discount Per Security: HKD 0.00315
Transaction Features: Rights Offering New Risk • Nov 25
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: HK$75.1m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Market cap is less than US$10m (HK$75.1m market cap, or US$9.66m). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (15% increase in shares outstanding). Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to HK$2.35, the stock trades at a trailing P/E ratio of 78.7x. Average trailing P/E is 9x in the Electronic industry in Hong Kong. Total returns to shareholders of 7.6% over the past three years. Reported Earnings • Oct 03
First half 2024 earnings released: HK$0.02 loss per share (vs HK$0.03 loss in 1H 2023) First half 2024 results: HK$0.02 loss per share (improved from HK$0.03 loss in 1H 2023). Revenue: HK$264.7m (up 16% from 1H 2023). Net loss: HK$3.91m (loss narrowed 19% from 1H 2023). Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Annuncio • Sep 24
China Energy Storage Technology Development Limited Announces Appointment of Wang Qi as Executive Director The board of directors of China Energy Storage Technology Development Limited together with its subsidiaries the (``Group'') announced, Mr. Wang Qi has been appointed as an executive Director of the Company with effect from 24 September 2024. Mr. Wang, aged 40, has over 15 years of working experience in operations management, resource management and big data management. Before joining the Group, Mr. Wang worked (i) as a purchasing manager at the England branch of Redcave Industry Ltd. in 2010, mainly responsible for telecommunications value-added service management, food retail and wholesale (Redcave Industry Ltd. was a supply chain management company affiliated with Cadbury Foods, the largest food company in the west of the UK); (ii) from 2013 to 2017, Mr. Wang worked in Xinhua (Daqing) Property Rights Exchange Co. Ltd. as the director of Market Center, mainly responsible for the development of national market and the establishment of operation center. Xinhua (Daqing) Property Rights Exchange Co. Ltd., which was a wholly-owned subsidiary of Xinhua (Daqing) International Petroleum Information Center Co., Ltd, provided venues and platform services for various property rights, public resources, assets, environmental energy trading activities; property rights transaction visas services, information, consulting, training, and financial advisory services as a comprehensive trading platform; and (iii) from 2018 to 2024, Mr. Wang served as the Chief Executive Officer of Shenzhen Doudou Interactive Technology Co. Ltd., mainly responsible for the daily operation management and business activities of the company which was a domestic start-up cloud computing and data service provider. Mr. Wang has extensive experiences in marketing management in different industries and in pursuing extensive personal network. Mr. Wang obtained a Bachelor of Business Management from the University of Liverpool and the National University of Ireland, and a Master of Science in Supply Chain Management from Dublin Institute of Technology. Annuncio • Aug 16
China Energy Storage Technology Development Limited to Report First Half, 2024 Results on Aug 29, 2024 China Energy Storage Technology Development Limited announced that they will report first half, 2024 results on Aug 29, 2024 New Risk • May 25
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 64% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (HK$480.3m market cap, or US$61.5m). Annuncio • Apr 30
China Energy Storage Technology Development Limited has completed a Follow-on Equity Offering in the amount of HKD 17.9034 million. China Energy Storage Technology Development Limited has completed a Follow-on Equity Offering in the amount of HKD 17.9034 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 11,260,000
Price\Range: HKD 1.59
Discount Per Security: HKD 0.0318
Transaction Features: Subsequent Direct Listing Annuncio • Apr 16
China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 17.9034 million. China Energy Storage Technology Development Limited has filed a Follow-on Equity Offering in the amount of HKD 17.9034 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 11,260,000
Price\Range: HKD 1.59
Discount Per Security: HKD 0.0318
Transaction Features: Subsequent Direct Listing Reported Earnings • Mar 30
Full year 2023 earnings released: EPS: HK$0.031 (vs HK$0.50 loss in FY 2022) Full year 2023 results: EPS: HK$0.031 (up from HK$0.50 loss in FY 2022). Revenue: HK$502.0m (down 5.1% from FY 2022). Net income: HK$5.26m (up HK$59.3m from FY 2022). Profit margin: 1.0% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings. Annuncio • Mar 16
China Energy Storage Technology Development Limited to Report Fiscal Year 2023 Results on Mar 28, 2024 China Energy Storage Technology Development Limited announced that they will report fiscal year 2023 results on Mar 28, 2024 Annuncio • Dec 21
China Energy Storage Technology Development Limited Announces Board Appointment China Energy Storage Technology Development Limited announced that Ms. Zhang Xiulin has been appointed as an independent non-executive Director and a member of audit committee of the Company with effect from 20 December 2023. The biographical details of Ms. Zhang are set out below: Zhang Xiulin Ms. Zhang'' aged 63, has over 20 years of experience in corporate management and human resources management. Ms. Zhang served as the executive vice president of Shanghai Resource Property Consultancy Co. Ltd. from 2002 to 2010 from 2011 to 2013, she served as the general manager of Shanghai Fujie Decoration Construction Co. Ltd., which is a joint venture company of Shanghai Resource Property Consultancy Co. Ltd., where she was mainly responsible for the company's annual budget planning, guiding the establishment and improvement of the company's various management systems, as well as the organizing and planning of the company's important meetings and major events. Ms. Zhang acted as the deputy secretary-general of the Shanghai Jiaxing Chamber of Commerce from 2013 to 2020, and was mainly responsible for event coordination and daily administrative management of the chamber. Ms. Zhang graduated from the Department of Business Management of Shanghai Polytechnic University in 1996 with a bachelor's degree, and later completed a postgraduate program in human resource development and management at East China Normal University in 2006. The Board announces that Ms. Zhang has been appointed as a member of the Audit Committee with effect from 20 December 2023. Following the appointment of Ms. Zhang, (i) the Company has three independent non-executive Directors, thus the number of independent non-executive Directors meets the minimum number required under Rule 3.10(1) of the Listing Rules; and (ii) the Audit Committee has three members and all members are non-executive Directors, thus meets the requirement under Rule 3.21 of the Listing Rules. New Risk • Oct 22
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Minor Risk Market cap is less than US$100m (HK$362.2m market cap, or US$46.3m). Annuncio • Sep 23
Link-Asia International MedTech Group Limited Announces Board Changes Link-Asia International MedTech Group Limited announces the following changes: Mr. Chak Chi Shing (``Mr. Chak'') has resigned as an independent non-executive Director and the chairman of the audit committee of the Company with effect from 23 September 2023 due to his own business commitment. Following Mr. Chak's resignation, Mr. Wu Chi King (``Mr. Wu'') has been appointed as the chairman of the audit committee of the Company and will cease to be the chairman of the remuneration committee but remain as a member of the remuneration committee with effect from 23 September 2023. Mr. Li Huiwu (``Mr Li'') will be appointed as the chairman of the remuneration committee. Following the resignation of Mr. Chak, the Board comprises six members, including four executive Directors and two independent non-executive Director. The current number of independent non-executive Director is less than three as required under Rule 3.10(1) of the Listing Rules. Mr. Chak was also the chairman of the audit committee of the Company. Following Mr. Chak's resignation, the Board is unable to fulfil the requirement of having three members on the audit committee under Rule 3.21 of the Listing Rules. The Company will ensure its compliance with the number and the composition of the independent non-executive Directors and the Board committees under the Listing Rules. The Company will make further announcement(s) as and when appropriate. Annuncio • Sep 07
Link-Asia International Medtech Group Limited Announces Executive Changes Link-Asia International MedTech Group Limited announced executive changes. The company announced appointment of Mr. Wu Chi King as an Independent Non-executive Director of the Company with effect from 6 September 2023. Mr. Wu Chi King (``Mr. Wu''), aged 41, received a Bachelor of Computer Science from Monash University and is a Certified Practising Accountant (CPA) of Certified Practising Accountant Australia. He has accumulated extensive experience in finance and accounting by working in various listed and sizable companies in Hong Kong. Mr. Wu is currently the financial controller of Hang Heung Cake Shop Company Limited, a private company incorporated in Hong Kong with limited liability which is a food product manufacturer. Mr. Wu is also an independent non-executive director of Palinda Group Holdings Limited, a company whose shares are listed on GEM of the Stock Exchange since September 2022; Mansion International Holdings Limited, a company whose shares are listed on GEM of the Stock Exchange since June 2021; and Wan Cheng Metal Packaging Company Limited, a company whose shares are listed on GEM of the Stock Exchange since June 2020. Mr. Wu will enter into an appointment letter as an independent non-executive Director with the Company for an initial term of three years, and will be subject to retirement by rotation and re-election at general meeting of the Company in accordance with the Company's articles of association. Mr. Wu is entitled to a directors' fee of HKD 240,000 per annum as specified in his letter of appointment, which is determined by the Board with reference to his duties and responsibilities in the Company, the prevailing market rate and the remuneration policy of the Company. Such remuneration is subject to review by the Remuneration Committee and the Board from time to time. CHANGE OF COMPOSITION OF BOARD COMMITTEES: Mr. Wu has be appointed as the member of the Audit Committee, the chairman of the Remuneration Committee and a member of the Nomination Committee with effect from 6 September 2023. Reported Earnings • Sep 04
First half 2023 earnings released: HK$0.03 loss per share (vs HK$0.14 loss in 1H 2022) First half 2023 results: HK$0.03 loss per share (improved from HK$0.14 loss in 1H 2022). Revenue: HK$228.5m (down 19% from 1H 2022). Net loss: HK$4.83m (loss narrowed 64% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings. Annuncio • Aug 18
Link-Asia International MedTech Group Limited to Report First Half, 2023 Results on Aug 31, 2023 Link-Asia International MedTech Group Limited announced that they will report first half, 2023 results on Aug 31, 2023 Annuncio • Aug 15
Link-Asia International MedTech Group Limited Announces Resignation of Li Yinxiang as Executive Director Link-Asia International MedTech Group Limited announced that Mr. Li Yinxiang (``Mr. Li'') has tendered his resignation as an executive Director of the Company with effect from 14 August 2023 due to personal health reason. Annuncio • Jun 13
Link-Asia International MedTech Group Limited Announces Executive Changes The board of directors of Link-Asia International MedTech Group Limited announced, Ms. Bian Sulan has been appointed as an executive Director of the Company with effect from 12 June 2023. Ms. Bian, aged 55, has over 30 years of working experience in marketing, promotion and media business management. Before joining the Group, Ms. Bian worked as the general director of a company mainly engaged in social media business in the PRC, mainly responsible to manage the company's daily operations, including but not limited to marketing promotion, customer management, product sales and review of the company brand development. She has extensive experience in sales planning, marketing management and wide personal networks in different industries. Mr. Yang Weidong has tendered his resignation as an independent non- executive Director and cease to be the member of the audit committee and nomination committee and the Chairman of the remuneration committee of the Company with effect from 12 June 2023 due to his own business commitment. Mr. Yang has confirmed that he has no disagreement with the Board and there are no others matters in respect of his resignation that need to be brought to the attention of the shareholders and the Stock Exchange. The Board would like to express its sincere gratitude to Mr. Yang for his valuable contribution to the Company during his tenure of service. Following the resignation of Mr. Yang, the Board comprises seven members, including five executive Directors and two independent non-executive Director. The current number of independent non-executive Director is less than three as required under Rule 3.10(1) of the Listing Rules. Mr. Yang was also the chairman of the Remuneration Committee, a member of the Nomination Committee and a member of Audit Committee of the Company. Following Mr. Yang's Resignation, the Board is unable to fulfil the requirement of having three members on the Audit Committee under Rule 3.21 of the Listing Rules. Annuncio • May 12
Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 08, 2023 Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 08, 2023, at 10:30 China Standard Time. Location: Units 59065912, 59th Floor, The Center, 99 Queen's Road Central, Hong Kong Queen’s Road Central Hong Kong Agenda: To receive, consider and adopt the audited consolidated accounts and reports of the directors and auditors of the Company and its subsidiaries for the year ended 31 December 2022; to re-appoint McMillan Woods CPA Limited as auditors of the Company and the board of directors of the Company be authorised to fix their remuneration; to re-elect Mr. Li Yinxiang and Mr. Liu Zhiwei as executive Directors of the Company and the Board be authorised to fix their director's remuneration; and to consider other matters. Annuncio • Feb 07
Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 96.0148 million. Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 96.0148 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 517,600,000
Price\Range: HKD 0.1855
Transaction Features: Subsequent Direct Listing Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non Executive Director Chi Shing Chak was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Nov 02
Less than half of directors are independent Following Executive Director Zhiwei Liu's arrival on 01 November 2022, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non Executive Director Chi Shing Chak was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annuncio • Nov 02
Link-Asia International MedTech Group Limited Appoints Liu Zhiwei as Executive Director, with Effect from 1 November 2022 Link-Asia International MedTech Group Limited appointed Mr. Liu Zhiwei as an executive Director of the Company with effect from 1 November 2022. Mr. Liu, aged 53, obtained a Specialist Certificate of General Higher Education in clinical Medicine from Sun Yat-sen University of Medical Sciences in 1992, a Bachelor's Degree in Clinical Medicine in Chinese and Western Medicine from Hunan University of Chinese Medicine in 2015 and an EMBA degree from Jilin University in 2017. In addition, Mr. Liu is currently an executive vice president of the Meixian Chamber of Commerce in the PRC. Prior to joining the Group, he was the chairman of Shenzhen Xinxin Medical Technology Development Co.,Ltd. and the chairman of Yuanta Chinese Medicine Chain (Shenzhen) Co. Ltd. Mr. Liu has over 30 years of experience in Chinese medical business and over 20 years of experience in the operation and management of Chinese medicine healthcare institutions. He also has solid theoretical knowledge in the field of Chinese medicine technology and health preservation by food. Reported Earnings • Sep 30
First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.07 loss in 1H 2021) First half 2022 results: HK$0.014 loss per share (improved from HK$0.07 loss in 1H 2021). Revenue: HK$281.9m (down 13% from 1H 2021). Net loss: HK$13.5m (loss narrowed 58% from 1H 2021). Reported Earnings • Sep 02
First half 2022 earnings released: HK$0.014 loss per share (vs HK$0.07 loss in 1H 2021) First half 2022 results: HK$0.014 loss per share (up from HK$0.07 loss in 1H 2021). Revenue: HK$281.9m (down 13% from 1H 2021). Net loss: HK$13.5m (loss narrowed 58% from 1H 2021). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings. Annuncio • Aug 18
Link-Asia International MedTech Group Limited to Report First Half, 2022 Results on Aug 31, 2022 Link-Asia International MedTech Group Limited announced that they will report first half, 2022 results on Aug 31, 2022 Annuncio • Jul 14
Link-Asia International Medtech Group Limited Announces Resignation of Duan Chuanhong as an Executive Director The board (the ``Board'') of director of Link-Asia International MedTech Group Limited (the ``Company'', together with its subsidiaries, the ``Group'') announced that Mr. Duan Chuanhong (``Mr. Duan'') has tendered his resignation as an executive Director of the Company with effect from 13 July 2022 to his desire to devote more attention and dedication to his other business engagements. Mr. Duan has confirmed that he has no disagreement with the Board and that there is no matter in relation to his resignation which should be brought to the attention of the shareholders of the Company. The Board would like to express its sincere gratitude to Mr. Duan for his contributions to the Company during his tenure as director of the Company. Annuncio • May 05
Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 07, 2022 Link-Asia International MedTech Group Limited, Annual General Meeting, Jun 07, 2022, at 11:00 China Standard Time. Location: Units 59065912, 59th Floor, The Center 99 Queen's Road Central Hong Kong Hong Kong Agenda: To receive, consider and adopt the audited consolidated accounts and reports of the directors and auditors of the company and its subsidiaries for the year ended 31 december 2021; to re-appoint McMillan Woods (Hong Kong) CPA Limited as auditors of the company and the board of directors of the company (the ``Board'') be authorised to fix their remuneration; to consider the re-election of Mr. Lin Dailian and Ms. Lin Xiaoshan as executive Directors of the company and the Board be authorised to fix their director's remuneration; and to consider the re-election of Mr. Chak Chi Shing as an independent non-executive Director of the company and the Board be authorised to fix his director's remuneration. Board Change • Apr 27
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 6 new directors. 1 experienced director. 1 highly experienced director. 3 independent directors (4 non-independent directors). Chief Executive Officer of TrekStor (Germany) and Director of TrekStor (Germany) Shimon Szmigiel is the most experienced director on the board, commencing their role in 2009. Independent Non Executive Director Chi Shing Chak was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Annuncio • Apr 20
Link-Asia International MedTech Group Limited to Report Fiscal Year 2021 Final Results on Apr 29, 2022 Link-Asia International MedTech Group Limited announced that they will report fiscal year 2021 final results on Apr 29, 2022 Reported Earnings • Apr 03
Full year 2021 earnings released: HK$0.078 loss per share (vs HK$0.46 loss in FY 2020) Full year 2021 results: HK$0.078 loss per share (up from HK$0.46 loss in FY 2020). Revenue: HK$675.5m (up 14% from FY 2020). Net loss: HK$46.4m (loss narrowed 73% from FY 2020). Annuncio • Mar 06
Link-Asia International MedTech Announces Management Changes The board (Board) of directors (Directors) of Link-Asia International MedTech Group Limited and together with its subsidiaries (Group) announced that Ms. Lin Xiaoshan (Ms. Lin) has been appointed as an executive Director of the Company with effect from 4 March 2022. The Board announced that Mr. Xia Xiaobing (Mr. Xia) has tendered his resignation as an executive Director of the Company with effect from 4 March 2022 to focus on his personal career development. Executive Departure • Sep 07
Company Secretary Keying Gao has left the company On the 31st of August, Keying Gao's tenure as Company Secretary ended after 1.3 years in the role. We don't have any record of a personal shareholding under Keying's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 10.13 years. Reported Earnings • Sep 05
First half 2021 earnings released: HK$0.07 loss per share (vs HK$0.20 loss in 1H 2020) The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: HK$324.8m (up 25% from 1H 2020). Net loss: HK$32.0m (loss narrowed 54% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 47% per year, which means it is performing significantly worse than earnings. Annuncio • Aug 26
Link-Asia International Medtech Group Limited Provides Earnings Guidance for the Six Months Ended 30 June 2021 Link-Asia International MedTech Group Limited provided earnings guidance for the six months ended 30 June 2021. The company announced that based on preliminary assessment and analysis of the Group's unaudited consolidated management accounts of the Group for the six months ended 30 June 2021 and information currently available to the Board, the Group is expected to record a loss attributable to owners of the Company for the Reporting Period of approximately HKD 32.1 million, representing a substantial decrease of approximately 54% as compared to corresponding period of 2020 of HKD 69.9 million. Annuncio • Jul 02
Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 23.005696 million. Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 23.005696 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 102,704,000
Price\Range: HKD 0.224
Discount Per Security: HKD 0.00672
Transaction Features: Subsequent Direct Listing Reported Earnings • Apr 02
Full year 2020 earnings released The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: HK$595.0m (down 5.5% from FY 2019). Net loss: HK$193.4m (loss widened 23% from FY 2019). Annuncio • Mar 18
Link-Asia International MedTech Group Limited to Report Fiscal Year 2020 Results on Mar 31, 2021 Link-Asia International MedTech Group Limited announced that they will report fiscal year 2020 results on Mar 31, 2021 Is New 90 Day High Low • Mar 10
New 90-day high: HK$0.63 The company is up 43% from its price of HK$0.44 on 10 December 2020. The Hong Kong market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 15% over the same period. Is New 90 Day High Low • Jan 29
New 90-day low: HK$0.34 The company is down 26% from its price of HK$0.46 on 30 October 2020. The Hong Kong market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 32% over the same period. Annuncio • Jan 12
Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 29.953 million. Link-Asia International MedTech Group Limited has completed a Follow-on Equity Offering in the amount of HKD 29.953 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 85,580,000
Price\Range: HKD 0.35
Discount Per Security: HKD 0.007
Transaction Features: Subsequent Direct Listing Annuncio • Jan 08
Link-Asia International Co. Ltd. Appoints Sun Xiaohu as an Independent Non-Executive Director and A Member of Audit Committee Link-Asia International Co. Ltd. announced that Dr. Sun Xiaohu has been appointed as an independent non-executive Director and a member of audit committee of the Company with effect from 6 January 2021. Is New 90 Day High Low • Dec 17
New 90-day high: HK$0.61 The company is up 53% from its price of HK$0.40 on 18 September 2020. The Hong Kong market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 8.0% over the same period. Is New 90 Day High Low • Nov 04
New 90-day high: HK$0.60 The company is up 13% from its price of HK$0.53 on 06 August 2020. The Hong Kong market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 9.0% over the same period. Annuncio • Oct 20
Link-Asia International Co. Ltd. Announces Executive Changes Link-Asia International Co. Ltd. announced that Mr. Bao Jinqiao has tendered his resignation as an independent non-executive Director, the member of the audit committee of the Company (the ``Audit Committee''), and the chairman of each of the remuneration committee of the Company (the``Remuneration Committee'') and the nomination committee of the Company (the``Nomination Committee'') with effect from 19 October 2020 in order to pursue his personal business commitments. Upon Mr. Bao's resignation, he ceased to be a member of Audit Committee, the chairman of the Remuneration Committee and the Nomination Committee. Mr. Lin Dailian has been appointed as the chairman of the Nomination Committee with effect from 19 October 2020. Mr. Yang Weidong has been appointed as the chairman of the Remuneration Committee and a member of the Nomination Committee with effect from 19 October 2020. Annuncio • Aug 22
Link-Asia International Co. Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Link-Asia International Co. Ltd. announced that they will report first half, 2020 results on Aug 28, 2020 